Navigation Links
QBC Diagnostics Awarded GSA Contract

PORT MATILDA, Penn., April 23, 2012 /PRNewswire/ -- QBC Diagnostics, a global manufacturer of hematology and infectious disease diagnostics equipment, announced today that the company has been awarded a U.S. General Services Administration (GSA) Schedule 66 Contract for Scientific Equipment and Services.

GSA's Scientific Equipment and Services Schedule 66 Contract provides federal agencies with scientific instruments for a wide variety of uses such as public safety, medical research, and laboratory diagnostics. Under contract number GS-07F-0306Y, QBC Diagnostics has been approved to sell to government agencies for all of their major product lines, including the QBC STAR Hematology Analyzer and the QBC ParaLens Advance Fluorescence Microscopy Attachment.

"We are thrilled to be able to offer an efficient and reliable means of supplying our government partners with our entire line of products," said Craig Stout, QBC Diagnostics' General Manager and Vice President. "QBC is highly committed to providing our customers with innovative tools such as our unique line of dry hematology analyzers and fluorescence microscopy products, and this contract further strengthens our past relationships with government agencies."

Currently, QBC has a number of its QBC STAR Hematology analyzers installed on over 250 U.S. Navy Vessels, including both surface and submarine forces. Working closely with the U.S. Department of State, QBC diagnostics also provides hematology solutions to more than 50 United States Embassies worldwide. The QBC ParaLens Advance can be found in a number of National Tuberculosis Programs around the globe, and is considered a leader in the field of fluorescence microscopy.

QBC Diagnostics is presently working on finalizing their contract price list with GSAAdvantage!®, which should be made available shortly. In the interim, QBC has asked that all inquiries pertaining to GSA pricing should be directed to their sales team for further information.

About QBC Diagnostics

QBC Diagnostics is a privately held company headquartered in Port Matilda, Pennsylvania.  The company manufactures a line of complete blood count analyzers and fluorescence microscopy products.  Additional information can be found by visiting the company website ( or by calling +1-814-692-7661.  Follow QBC on Twitter or Facebook for further updates.

SOURCE QBC Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Names Steve Rusckowski as President and CEO
2. FDA Clears the Quest Diagnostics Simplexa® C. difficile Molecular Test
3. Everist Genomics Develops Worlds First Comprehensive Companion Diagnostics and Prognostics Portfolio for Early Diagnosis and Improved Treatment of Colorectal Cancer
4. QIAGEN Expands Access to State-of-the-art HPV Screening in China Through Co-marketing Agreement With KingMed Diagnostics
5. Quest Diagnostics to Speak at the 2012 Barclays Capital Global Healthcare Conference
6. Hemostasis Diagnostics Market Leading Suppliers and Emerging Market Entrants
7. Quest Diagnostics Declares Quarterly Cash Dividend
8. Quest Diagnostics to Speak at the 2012 RBC Capital Markets Healthcare Conference
9. Care360® EHR From Quest Diagnostics Honored by Black Books 2012 Rankings and Capterras Top 20 List
10. Quest Diagnostics Offers Industry-First 30-Day Ambulatory EHR Implementation Guarantee for Hospitals and IDNs
11. Aria Diagnostics Announces Name of New Non-Invasive Prenatal Assay - Harmony Prenatal Test™ - and Publication of Study on Specimen Transport
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , , , WHEN: , , ... , , , LOCATION: , , , Online, with free registration ... PANELISTS:  , , , Frost & Sullivan,s Global Vice President of ... Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... witnessing an exceptional era. Several new demand spaces, such as innovative ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from reveals that behind the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
Breaking Medicine News(10 mins):